Evommune (EVMN) Leases (2024 - 2025)
Evommune (EVMN) has disclosed Leases for 2 consecutive years, with $1.5 million as the latest value for Q4 2025.
- On a quarterly basis, Leases rose 211.23% to $1.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 million, a 211.23% increase, with the full-year FY2025 number at $1.5 million, up 211.23% from a year prior.
- Leases was $1.5 million for Q4 2025 at Evommune, up from $160000.0 in the prior quarter.
- In the past five years, Leases ranged from a high of $1.5 million in Q4 2025 to a low of $160000.0 in Q3 2025.